Skip to content

Enliven Therapeutics ELVN MA — Income Taxes Paid Net

Similar metrics at other companies

Syndax Pharmaceuticals logo
SNDXMA — Income Taxes Paid Net
$2.5
Addus HomeCare logo
ADUSTN — Income Taxes Paid Net
$178.25K
Monte Rosa Therapeutics, Inc. logo
GLUEMA — Income Tax Paid State And Local After Refund Received
$143K+11,340%
UBS
UBSIMD — Income Taxes Paid Net
$1.49M-3.3%
Addus HomeCare logo
ADUSOther States — Income Taxes Paid Net
$311.75K-57.7%
Syndax Pharmaceuticals logo
SNDXTN — Income Taxes Paid Net
$17.5

Other financials

Income statement

See full
Operating income-$27.8M+12.2%
Net income-$23.6M+17.2%
EPS (diluted)-$0.38+33.3%

Balance sheet

See full
Cash & equivalents$132.2M+30.0%
Total debt$302.0K-56.9%
Total equity$453.4M+57.3%
Total assets$464.9M+53.6%

Cash flow

See full
Operating cash flow-$19.3M+20.0%
CapEx--100%
Free cash flow-$19.3M+20.1%

Valuation

See full
Market cap$3.47B+143%
Enterprise value$3.34B+156%

Returns & leverage

See full
Return on equity-26.6%-3.5pp
Debt / equity0.0×
Current ratio40.3×+19.3×

Where this comes from

Reported directly by Enliven Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Enliven Therapeutics’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enliven Therapeutics's ma — income taxes paid net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enliven Therapeutics's MA — income taxes paid net?
Enliven Therapeutics (ELVN) reported MA — income taxes paid net of -$0 in Q4 2025.
How has Enliven Therapeutics's MA — income taxes paid net changed year-over-year?
Enliven Therapeutics's MA — income taxes paid net decreased by 100.0% year-over-year, from $12.75K to -$0.
What does MA — income taxes paid net mean?
Represents the actual cash outflow for income taxes related to the specific segment, net of any refunds received. This metric reflects the tax burden or tax recovery position of the segment's operations within a specific jurisdiction. It is a key indicator of the segment's cash flow impact from tax obligations.